Resverlogix (RVX) Competitors C$0.04 -0.01 (-11.11%) As of 03/31/2025 01:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesBuy This Stock RVX vs. GSD, IBT, AEZS, LTY, ACST, REUN, NEPT, ATE, SBM, and BCTShould you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include Devonian Health Group (GSD), IBEX Technologies (IBT), Aeterna Zentaris (AEZS), Liberty Biopharma (LTY), Acasti Pharma (ACST), Reunion Neuroscience (REUN), Neptune Wellness Solutions (NEPT), Antibe Therapeutics (ATE), Sirona Biochem (SBM), and BriaCell Therapeutics (BCT). These companies are all part of the "biotechnology" industry. Resverlogix vs. Devonian Health Group IBEX Technologies Aeterna Zentaris Liberty Biopharma Acasti Pharma Reunion Neuroscience Neptune Wellness Solutions Antibe Therapeutics Sirona Biochem BriaCell Therapeutics Resverlogix (TSE:RVX) and Devonian Health Group (CVE:GSD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk. Is RVX or GSD more profitable? Resverlogix has a net margin of 0.00% compared to Devonian Health Group's net margin of -32.50%. Resverlogix's return on equity of 6.06% beat Devonian Health Group's return on equity.Company Net Margins Return on Equity Return on Assets ResverlogixN/A 6.06% -34.90% Devonian Health Group -32.50%-23.31%-8.12% Does the MarketBeat Community prefer RVX or GSD? Resverlogix received 285 more outperform votes than Devonian Health Group when rated by MarketBeat users. Likewise, 84.01% of users gave Resverlogix an outperform vote while only 65.79% of users gave Devonian Health Group an outperform vote. CompanyUnderperformOutperformResverlogixOutperform Votes31084.01% Underperform Votes5915.99%Devonian Health GroupOutperform Votes2565.79% Underperform Votes1334.21% Which has stronger earnings & valuation, RVX or GSD? Resverlogix has higher earnings, but lower revenue than Devonian Health Group. Devonian Health Group is trading at a lower price-to-earnings ratio than Resverlogix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioResverlogixN/AN/A-C$2.81M-C$0.02-1.98Devonian Health GroupC$9.75M3.80-C$3.17M-C$0.02-12.50 Does the media refer more to RVX or GSD? In the previous week, Resverlogix's average media sentiment score of 0.00 equaled Devonian Health Group'saverage media sentiment score. Company Overall Sentiment Resverlogix Neutral Devonian Health Group Neutral Which has more volatility and risk, RVX or GSD? Resverlogix has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Devonian Health Group has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. SummaryResverlogix beats Devonian Health Group on 6 of the 10 factors compared between the two stocks. Remove Ads Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVX vs. The Competition Export to ExcelMetricResverlogixBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$7.92MC$109.00MC$5.63BC$5.67BDividend Yield7.02%3.78%5.34%6.44%P/E Ratio-1.983.1123.6430.93Price / SalesN/A4,105.15371.25615.45Price / Cash132.5012.7538.1783.21Price / Book-0.1735.726.733.59Net Income-C$2.81M-C$91.48MC$3.20BC$299.69M7 Day PerformanceN/A-3.55%-4.57%-1.72%1 Month PerformanceN/A59.42%-0.22%-0.01%1 Year PerformanceN/A80.03%7.96%27.89% Resverlogix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVXResverlogixN/AC$0.04-11.1%N/A-33.3%C$7.92MN/A-1.9819Gap DownGSDDevonian Health GroupN/AC$0.25+4.2%N/A+16.3%C$37.06MC$9.75M-12.506Gap UpIBTIBEX TechnologiesN/AC$1.44flatN/A+0.7%C$35.54MC$5.77M11.52N/AAEZSAeterna ZentarisN/AN/AN/AN/AC$25.37MC$2.37M-2.6120LTYLiberty BiopharmaN/AC$2.00+∞N/A+0.0%C$21.54MN/A-12.66N/AGap UpACSTAcasti PharmaN/AC$0.58+1.8%N/A+0.0%C$18.19MC$2.71M-1.2132REUNReunion NeuroscienceN/AN/AN/AN/AC$16.64MC$4.86M-0.43190Gap DownNEPTNeptune Wellness SolutionsN/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap DownATEAntibe TherapeuticsN/AN/AN/AN/AC$15.64MC$9.71M-0.8411SBMSirona BiochemN/AC$0.06-7.7%N/A-7.7%C$15.41MC$683,768.00-6.00N/AGap DownHigh Trading VolumeBCTBriaCell TherapeuticsN/AC$5.79-0.3%N/A+35.6%C$14.93MN/A-4.3716Gap Up Remove Ads Related Companies and Tools Related Companies Devonian Health Group Competitors IBEX Technologies Competitors Aeterna Zentaris Competitors Liberty Biopharma Competitors Acasti Pharma Competitors Reunion Neuroscience Competitors Neptune Wellness Solutions Competitors Antibe Therapeutics Competitors Sirona Biochem Competitors BriaCell Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:RVX) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Resverlogix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVX Stock Free RVX Stock Alerts